Currently out of the existing stock ratings of Graham Doyle, 14 are a BUY (30.43%), 20 are a HOLD (43.48%), 12 are a SELL (26.09%).

Graham Doyle

Work Performance Price Targets & Ratings Chart

Analyst Graham Doyle, currently employed at UBS, carries an average stock price target met ratio of 30.79% that have a potential upside of 5.78% achieved within 90 days.

Graham Doyle’s has documented 74 price targets and ratings displayed on 7 stocks. The coverage is on Healthcare, Consumer Defensive sectors.

Most recent stock forecast was given on GEHC, GE HealthCare Technologies at 16-Jul-2026.

Wall Street Analyst Graham Doyle

Analyst best performing recommendations are on PHG (KONINKLIJKE PHILIPS NV ADR).
The best stock recommendation documented was for PHG (KONINKLIJKE PHILIPS NV ADR) at 9/2/2022. The price target of $16.49 was fulfilled within 7 days with a profit of $1.47 (9.79%) receiving and performance score of 13.98.

Average potential price target upside

of $15.72 (22.14%) on ALC (ALCON AG).
of $5.81 (7.87%) on GEHC (GE HEALTHCARE TECHNOLOGIES).
of $2.12 (10.44%) on PHG (KONINKLIJKE PHILIPS NV ADR).

SNN Smith & Nephew SNATS PHG Koninklijke Philips NV ADR FMS Fresenius Medical Care FSNUY Fresenius SE KGaA ADR ALC Alcon AG GEHC GE HealthCare Technologies CL Colgate-Palmolive Company

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Caitlin Cronin (CANACCORD)